Egyptian Drug Authority Discusses Enhancing Investment Cooperation with Danish Companies
The fifth edition of the Africa Health ExCon 2026 witnessed an important meeting between Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Drug Authority (EDA), and a high-level delegation of Danish companies specializing in the medical sector.
This meeting aimed to discuss opportunities for joint cooperation and attract more foreign investment to the Egyptian market. This step is part of the state's strategy to develop the healthcare sector and localize the manufacturing of medical devices and supplies.
During the meeting, Dr. Al-Ghamrawi reviewed the significant developments currently taking place in Egypt's pharmaceutical and medical supplies sector. He also highlighted the efforts made by the Egyptian Drug Authority to facilitate investment procedures and provide a stimulating work environment for international companies wishing to operate within Egypt.
For their part, representatives of the Danish companies expressed great interest in the Egyptian market, emphasizing the importance of partnering with Egypt as a key gateway to African markets. These discussions come within the framework of Egypt's continuous efforts to improve the efficiency of the medical system and provide the latest global technologies to its citizens.
These meetings conclude the activities of the Africa Health ExCon, which serves as a vital platform for exchanging expertise between Egypt and developed countries in the medical field. It is expected that these discussions will lead to new agreements that contribute to supporting the national economy and developing health services in the country.